Hospital pharmacist prescribing in the new age

Pharmaceutical Journal

Volumn 257, Issue 6907, 1996, Pages 286-288

  Cross, Michael A ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 3643083358     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Medicinal products: Prescription by Nurses etc Bill. London: HM Stationery Office, 1992.
2. Vogel DP. Patient focused care. Am J Hosp Pharm 1993;50.2321-9.
3. Trusts face liability time bomb. Healthcare Management 1995;Mar:3.
4. Galt KA. The key to pharmacist prescribing: collaboration. Am J Health-System Pharm 1995;52:1696-9.
5. Manase HR Jr. Medication use in an imperfect world. Bethesda, MD: ASHP Research and Education Foundation, 1989.
6. Schneider PJ, Gift MG, Yu-Ping L, Rothermich EA, Sill BE. Cost of medication-related problems at a university hospital. Am J Health-System Pharm 1995;52:2415-8.
7. Bootman JL. Drug related morbidity and mortality. A cost-of-illness model. Arch Intern Med 1995;155:1949-56.
8. Coleman LT, Adams WC, Gong WC. Pharmacist as a primary care provider in a tuberculosis clinic. Am J Hosp Pharm 1983;40:278-81.
9. Furmaga EM. Pharmacist management of a hyperlipidemia clinic. Ibid 1993;50:91-5.
10. Rosen CE, Holmes S. Pharmacist's impact on chronic psychiatric outpatients in community mental health. Ibid 1978;35:704-8.
11. Stimmel GL, McGhan WF, Wincor MZ, et al. Comparison of pharmacist and physician prescribing for psychiatric inpatients. Ibid 1982;39:1483-6.
12. Ellinoy BJ, Mays JF, McSherry PB. A pharmacy outpatient monitoring program providing primary medical care to selected patients. Ibid 1974;31:254-713.
13. McKenney JM, Slining JM, Henderson HR. The effect of clinical pharmacy services on patients with essential hypertension. Circulation 1973;48:1104-11.
14. Hawkins DW, Fiedler FP, Douglas HL. Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. Am J Hosp Pharm 1979;36:1321-5.
15. Gray DR, Garabedian-Ruffolo SM, Chretien SD. Cost justification of a clinical pharmacist managed anticoagulation clinic. Drug Intell Clin Pharm 1985;19:575-80.
16. Cummings DM, Corson M, Seaman JJ. The effect of clinical pharmacy services provided to ambulatory patients on hospitalisation. Am J Pharm 1984;156:44-50.
17. Dean J, Acomb J. A pharmacist managed lithium clinic. Hosp Pharmacist 1995,2:150-2.
18. Parekh R, Ghee C. Evaluation of a pharmacist controlled anticoagulation clinic. Br J Pharm Prac 1987;(10):370-81.
19. Carmichael JM. Do pharmacists need prescribing privileges to implement pharmaceutical care? Am J Health-System Pharm 1995;52:1699-701.
20. Stimmel GL, Mcghan WF. The pharmacist as prescriber of drug therapy: The USC pilot project. Drug Intell Clin Pharm 1981;15:665-72.
21. Conte RR. Training and activities of pharmacist prescribers in a California pilot project. Am J Hosp Pharm 1986;43:375-80.
22. Boyce R. ASHP should take the lead in developing pharmacist-prescribing guidelines. Ibid 1987,44:2253.
23. Ukens C. RPhs expand prescriptive authority but still lagging. Drug Topics 1994;May 9:16.
24. Stimmel GL. Political and legal aspects of pharmacist prescribing. Am J Hosp Pharm 1983;40:1343-4.
25. Santell JP. ASHP national survey of hospital-based pharmaceutical services. Am J Health-System Pharm 1995;52:1179-98.
26. Wittenburg AStJ. Obtaining prescribing authority for pharmacists: Lessons learned. Ibid 1995;52:1616-26.